361 related articles for article (PubMed ID: 32801637)
1. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
2. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
3. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
4. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
5. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
6. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
[TBL] [Abstract][Full Text] [Related]
7. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
8. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
[TBL] [Abstract][Full Text] [Related]
9. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
11. Enhancing solubility and bioavailability of coenzyme Q
Lamichhane S; Seo JE; Keum T; Noh G; Bashyal S; Cho SW; Lee EH; Lee S
Arch Pharm Res; 2022 Jan; 45(1):29-37. PubMed ID: 35128573
[TBL] [Abstract][Full Text] [Related]
12. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
13. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
14. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
16. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
17. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
18. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
20. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
